Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2023 (1)
  • 2022 (3)
  • 2021 (3)
  • 2019 (1)

Subject

  • Prescription Drugs (4)
  • Seizures (Drugs/Property) (4)
  • Synthetic drugs (4)
  • Diversion Division (3)
  • Drug Trafficking (3)
  • Major Law Enforcement Operation (3)
  • Overdose (3)
  • Pharmaceuticals/Pharmacists/Physicians (3)
  • Task Forces/Task Force Officers (3)
  • Arrests/Convictions - Major (2)
  • Guns/Weapons (1)
  • Outreach/Drug Prevention (1)
  • Prevention/Education - DEA websites GSAD, JTT etc (1)
  • Public and Media Affairs - also see Congressional Affairs (1)

Drug Name

  • Fentanyl (153)
  • Cocaine (116)
  • Heroin (97)
  • Synthetic Opioids (84)
  • Opioids (55)
  • Methamphetamine (54)
  • Oxycodone (23)
  • Marijuana (Cannabis) (14)
  • Hydromorphone (7)
  • Morphine (5)
  • Ecstasy/MDMA (4)
  • K2/Spice (4)
  • Steroids (4)
  • Methadone (2)
  • Amphetamines (1)
  • Ketamine (1)
  • Marijuana Concentrates (1)
  • Xylazine (1)
  • Benzodiazepines (6)
  • Synthetic Bath Salts or Designer Cathinones (2)

Field Division

  • Seattle (5)
  • St. Louis (3)
  • Atlanta (2)
  • Miami (2)
  • New England (2)
  • New York (2)
  • Houston (1)
  • Los Angeles (1)
  • Rocky Mountain (1)
  • Washington, DC (8)
Clear All Results
PRESS RELEASE

Consent Decree Approved Among the U.S. and Cumberland, M.D. based Pharmacy and Pharmacist

July 06, 2023
Baltimore, Maryland - U.S. District Judge Lydia K. Griggsby approved the United States’ consent decree with John A. Beckman, a Cumberland, Maryland based pharmacist, and Beckman’s Greene Street Pharmacy, Inc. (“Beckman’s Pharmacy”), resolving the United States’ civil allegations that Beckman and Beckman’s Pharmacy violated the Controlled Substances Act (“CSA”) in...
July 06, 2023
PRESS RELEASE

Winchester Man Sentenced to Prison Time for Eutylone & "Ecstasy" Distribution

June 27, 2022
HARRISONBURG, Va. – A Winchester, Virginia man, who distributed Eutylone, commonly marketed by drug dealers as “Molly” or “Ecstasy” was sentenced last week to 72 months in federal prison. Lamont Antoine Parson, 40, pled guilty in November 2021 to one count of conspiracy to distribute and possess with the intent...
June 27, 2022
PRESS RELEASE

Oxon Hill Man Sentenced to Over 10 Years in Federal Prison for a Drug Distribution Conspiracy and for Illegal Possession of Stolen Firearms

May 06, 2022
Greenbelt, Md. – U.S. District Judge Theodore D. Chuang sentenced Zaid Rushdan, age 41, of Oxon Hill, Maryland, yesterday to 126 months in federal prison, followed by seven years of supervised release, on charges of conspiracy, possession with intent to distribute controlled substances, and possession of stolen firearms. The sentence...
May 06, 2022
PRESS RELEASE

DEA Serves Immediate Suspension Order on Northgate Pharmacy in Waldorf, Maryland

January 27, 2022
Washington, D.C., - Jarod Forget, Special Agent in Charge of the DEA Washington Division, announced the issuance of an Immediate Suspension Order (ISO) at Northgate Pharmacy, located at 3973 Saint Charles Parkway, Waldorf, Maryland, today. This morning, members of the Drug Enforcement Administration (DEA) Washington Division’s Tactical Diversion Squad, along...
January 27, 2022
PRESS RELEASE

Federal Consent Decree Permanently Bans Baltimore-Based Physician Assistant from Prescribing Opioids and Controlled Substances

November 19, 2021
Baltimore, Md., – U.S. District Judge Deborah L. Boardman has approved a consent decree that permanently enjoins Elizabeth J. Allen, a Baltimore-based physician assistant, from prescribing opioids and other controlled substances, resolving the United States’ civil allegations that Allen violated the Controlled Substances Act (CSA) in illegally prescribing opioids. Under...
November 19, 2021
PRESS RELEASE

DEA Washington Chief Issues Public Safety Alert: Dangerous Increase in Fake Rx Pills Containing Fentanyl

September 27, 2021
Washington, D.C. – Today, Jarod Forget, Special Agent in Charge of the DEA Washington Division issued a Public Safety Alert warning Maryland, Virginia, and Washington, D.C. residents of the alarming increase in the lethality and availability of fake prescription pills containing fentanyl in our area. This DEA Public Safety Alert...
September 27, 2021
PRESS RELEASE

DEA Washington Launches New Conference Series to Work with Healthcare Professionals & Help End the Overdose Crisis

April 22, 2021
The DEA Washington Division, an agency currently working to expand partnerships to offer targeted, full-scope solutions for the drug problems in Maryland, Washington DC, and Virginia, today introduced a new webinar series, “Empowering DMV Healthcare Professionals.” The idea for this unique concept was crystalized during the pandemic, when overdose rates...
April 22, 2021
PRESS RELEASE

Norton doctor pleads guilty to illegally prescribing prescription drugs

December 20, 2019
ABINGDON, Va. – Dr. Raymond Michael Moore, 61, of Wise, Va., who had a medical practice in Norton, pleaded guilty yesterday in United States District Court in Abingdon, to 14 federal charges, including illegally prescribing more than 25,000 oxycodone pills, more than 17,000 hydrocodone pills, and more than 10,000 benzodiazepine...
December 20, 2019
Showing 1 - 8 of 8 results
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster